Search results
Results From The WOW.Com Content Network
The pregnancy category of a medication is an assessment of the risk of fetal injury due to the pharmaceutical, if it is used as directed by the mother during pregnancy. It does not include any risks conferred by pharmaceutical agents or their metabolites in breast milk. Every drug has specific information listed in its product literature.
Australia's categorization system takes into account birth defects, the effects around birth or when the mother gives birth, and problems that will arise later in the child's life due to the drug taken. The system places them into a category based on the severity of the consequences that the drug can have on the infant when it crosses the placenta.
Opioids can cross both the placental and blood-brain barriers, which poses risks to fetuses and newborns exposed to these drugs before birth. This exposure to opioids during pregnancy can lead to potential obstetric complications, including spontaneous abortion, abruption of the placenta, pre-eclampsia, prelabor rupture of membranes, and fetal death.
Pages in category "Drugs and pregnancy" The following 6 pages are in this category, out of 6 total. This list may not reflect recent changes. ...
Ozempic, Wegovy, Mounjaro, Zepbound lead to weight loss, which can help fertility in women with obesity. Doctors warn about birth control, pregnancy risks.
Teratogens are classified in four main categories: Drugs in pregnancy – in addition to environmental chemicals, includes recreational drug use and pharmaceutical drugs. Vertically transmitted infections; Radiation, such as X-rays; Mechanical forces, such as oligohydramnios; Teratogens affect the fetus by various mechanism including:
Initially, fewer studies documented risks of prenatal exposure to DES on males (referred to as "DES sons"). In the 1970s and early 1980s, studies published on prenatally DES-exposed males investigated increased risk of testicular cancer, infertility and urogenital abnormalities in development, such as cryptorchidism and hypospadias.
A median of 288 days (274 days from the date of ovulation) for first-time mothers and 283 days (269 days from the date of ovulation) for mothers with at least one previous pregnancy was found by a 1990 study of 114 white, private-care patients with uncomplicated pregnancies and spontaneous labor. The authors suggest that excluding pregnancies ...